Pharmaceutical

AMA urges coverage of obesity treatments as payers balk...

The American Medical Association Monday called on insurance companies, employers...

Study suggests Covid rebound is far more common with Pa...

A small and preliminary study published Monday seems to indicate that patients r...

Opinion: Ohio has enshrined the right to an abortion. B...

Ohio has enshrined the right to an abortion. But major obstacles remain for pati...

Life expectancy for men in U.S. falls to 73 years — six...

American men's life expectancy is now 73.2 years, compared with women's 79.1. Wh...

Is there a bigger move being planned at Cigna?

An analyst has questions about Cigna's potential efforts to sell its Medicare Ad...

STAT+: Michigan bill that would pare back pharma liabil...

A one-of-a-kind law in Michigan that prevents the state government and residents...

These are the need-to-know biotech stories from this we...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Former MIT biologist, who lost positions after e...

Former MIT star biologist David Sabatini, who lost his position after he was acc...

STAT+: Pharmalittle: Wegovy cuts heart attack risk in m...

Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a la...

NYU researchers tackle the challenge of making MRI mach...

MRI machines typically cost between $1 million and $3 million. NYU radiologists ...

Opinion: Congress must reauthorize the National Advisor...

Congress must reauthorize the National Advisory Committee for Seniors and Disast...

STAT+: Eli Lilly’s chief scientist on new obesity drug ...

An interview with Eli Lilly’s chief scientist featured a discussion of new obesi...

The U.K. just cleared a drug to prevent breast cancer. ...

Doctors in the U.S. have long prescribed preventive drugs for people at risk of ...

STAT+: Novo Nordisk wants to be a cardiovascular compan...

“We have a clear vision of being an established cardiovascular company, just as ...

STAT+: Patients loved Carbon Health’s diabetes program....

Patients loved Carbon Health's telehealth-based program for managing diabetes. T...

STAT+: In first test for base editing, Verve’s one-time...

Verve Therapeutics said that the first 10 people to receive a one-time treatment...